Stock listing

Nervgen Pharma Corp.

Selected listing: 9UA · DUS · EUR · DE

Nervgen Pharma Corp. (Dusseldorf:9UA), Health Technology. Latest release Sep 25, 2026: NervGen to Restate Previously Filed Financial Statements Recognizing…

9UA:DUSEURDEUpdated October 3, 2026

Ticker: Dusseldorf:9UA
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Dusseldorf
Currency: EUR

Latest news from Nervgen Pharma Corp.

NervGen to Restate Previously Filed Financial Statements Recognizing Non-Cash Accounting Adjustments

September 25, 2026

NervGen to Host Inaugural R&D Day on September 30, 2026

September 9, 2026

NervGen Reports Second Quarter 2026 Financial Results and Provides Business Updates

August 13, 2026

NervGen Announces Positive Independent, Blinded Biomechanical Gait Analyses Demonstrating Genuine Neural Recovery with NVG-291 in Phase 1b/2a CONNECT SCI Study

May 26, 2026

NervGen Announces Proposed Public Offering of Securities

May 21, 2026

All Nervgen Pharma Corp. news →

Research Nervgen Pharma Corp.

Nervgen Pharma Corp. company profile

View the public company page for Nervgen Pharma Corp. on 6ix.

Nervgen Pharma Corp. news

Read company news and market updates connected to Nervgen Pharma Corp..

Nervgen Pharma Corp. investor events

Find investor webinars, events, and replay context for Nervgen Pharma Corp..